Open Access

Flow-regulated lymphatic vasculature development and signaling

Vascular Cell20146:14

DOI: 10.1186/2045-824X-6-14

Received: 6 May 2014

Accepted: 29 June 2014

Published: 9 July 2014

Abstract

The role of blood flow in regulating signaling pathways and gene expression in the blood vasculature is well known. Recent studies have identified equally important roles of flow-mediated signaling in the lymphatic circulation including control of lymphatic vascular growth, remodeling, regeneration and maintenance of the lymphatic fate. In this review, we summarize these advances focusing on the role of fluid dynamics in control of lymphatic vasculature formation.

Keywords

Flow Shear stress Signaling Lymphatic endothelial cells Lymphatic vascular development

Introduction

Blood flow generates shear stress that plays critical role in regulation of vascular growth and remodeling while disturbed shear is central to a number of important vascular disease processes. Thus, physiological shear forces regulate expression of transcription factors such as c-Fos and Egr-1, growth factors (PDGF-A, PDGF-B, TGF-β) and integrins among other molecules [14]. On the other hand, disrupted blood flow dynamics play a key role in initiation and propagation of atherosclerosis and neointima growth [58]. While flow-mediated effects on vascular biology are well described little attention, until recently, has been paid to the effects of fluid flow and shear stress in the lymphatic vasculature.

Lymphatic and blood vasculatures are closely related but yet distinctly different vascular systems. The lymphatic vasculature develops from embryonic venous circulation in a series of well-defined steps that are initiated by a fate change in a subset of endothelial cells (ECs) in the cardinal vein that begin expressing lymphatic markers. These newly defined lymphatic endothelial cells (LECs) then migrate out of the cardinal vein forming jugular lymph sacs that then sprout, giving rise to the entire lymphatic vascular network [9].

Unlike the blood vasculature which is a closed system, lymphatic circulation is open with blind-ended lymphatic capillaries serving as an entry point for the interstitial fluid and immune cells that are then transported via progressively enlarging collecting vessels to the thoracic duct that then empties into subclavian vein. Furthermore, while blood flow is propelled by rhythmic contractions of the heart, mammalian lymphatic circulation is driven by a combination of hydrostatic forces and skeletal muscle contraction in the limbs augmented by opening and closing of lymphatic valves. As a result, the lymphatic flow is slower and more irregular than blood flow.

Lymphatic vessels serve a variety of roles including draining interstitial fluid and macromolecules extravasated from blood vessels and returning them to blood circulation as well as facilitating immune cell trafficking and absorption of lipids. Therefore, lymphatic circulation is important for the regulation of interstitial fluid balance, tissue homeostasis and immune surveillance. Abnormal development or malfunction of lymphatic vessels is associated with pathological conditions such as lymphedema, late-onset obesity, hypertension and cardiovascular diseases including atherosclerosis [1015].

Although LECs, similarly to blood endothelial cells (BECs), have the ability to sense flow-mediated signaling, the role played by this signaling in lymphatic vasculature development and function is still poorly understood. Recent studies have identified contributions of lymphatic shear stress signaling to the regulation of lymphatic vascular growth, remodeling and lymphatic fate maintenance that will be the subject of this review.

Flow-mediated signaling in lymphatic endothelial cells

In mammals, the lymphatic vasculature is composed of lymphatic capillaries (also known as initial lymphatics), pre-collectors and larger collecting lymphatic vessels. Lymphatic capillaries are blind-ended structures consisting of a single layer of overlapping ECs that lack pericyte coverage and have little or no basement membrane [9]. Similar to BECs, LECs can sense flow. When cultured in 3D collagen gels and subjected to interstitial fluid flow (flow through the junctions into the lumen), LECs show distinct morphological changes including formation of long extensions and large vacuoles. In contrast, in BECs, interstitial fluid flow causes increased networking and multicellular tubulogenesis [16]. Although LECs and BECs express some common markers, they possess distinct gene expression profiles. Interstitial flow mediated different cellular responses in BECs and LECs may attribute to different signaling pathways activated by flow in these two cell types. Interestingly, in response to shear flow (flow down the lumen of the vessels), LECs do not display changes in morphology. Instead, they align along the axis of the flow and down-regulate expression levels of pan-cadherins leading to reduced LEC barrier function [16]. Taken together, these data indicate that LECs have the ability to sense distinct signals mediated by different types of flow and to respond differentially.

LECs can also detect changes of shear stress magnitude and adjust their barrier function accordingly [17]. Increasing shear stress magnitude enhances lymphatic endothelial barrier function indicated by increased transendothelial electrical resistance (TER) [17]. Mechanistically, Rac1, a small Rho family GTPase, is involved in the signaling responsible for this process as blockade of Rac1 activity significantly reduces the enhancement of lymphatic endothelial barrier function in response to increased shear stress [17]. It is known that cAMP/PKA signaling pathway can promote enhanced endothelial barrier function, which can also activate Rac1 [1824]. Of note, inhibition of PKA activity did not affect shear stress-mediated enhancement of lymphatic endothelial barrier function [17] suggesting that shear-induced activation of Rac1 is not PKA-dependent.

Flow-regulated lymphatic vasculature growth

Recently, an increasing body of evidence has pointed to an important role of fluid flow in lymphatic vasculature formation. For example, it has been shown that fluid flow can work synergistically with growth factors such as VEGF to promote lymphangiogenesis [25]. In a 3D fibrin gel system, in which fibrin gel is mixed with a fibrin-bound form of VEGF (α2-PI1–8-VEGF121) and LECs which then are pipetted into an interstitial flow culture chamber; interstitial flow enhances the effects of the fibrin-bound VEGF (α2-PI1–8-VEGF121) in promoting lymphatic network formation [25]. Notably, in this system, lymphatic structures are formed in parallel to flow only under the condition of the combined fibrin-bound VEGF (α2-PI1–8-VEGF121) and interstitial flow [25]. This result is correlated with interstitial flow induced changes of the extracellular distribution of soluble matrix metalloproteinases (MMPs) that release fibrin-bound VEGF (α2-PI1–8-VEGF121) to form a VEGF gradient [25].

The role of interstitial fluid flow in lymphangiogenesis has been investigated in vivo using a mouse skin regeneration model [26, 27]. In this model, a circumferential section of tail skin is removed midway up the tail resulting in completely interrupted lymphatic vascular network whereas big blood vessels remain intact. A diameter-matched silicone sleeve was placed over the wound and fixed in place to the intact skin on the proximal and distal edges. 0.3% type I rat tail collagen solution was injected into the wound under the sleeve and allowed to gel; this formed a collagen dermal equivalent (CDE) [26]. During tissue regeneration, interstitial fluid channels are formed in CDE prior to the formation of lymphatic vessels, which bridge the distal and proximal portions of the lymphatic vessels in intact tail skin. Once formed, the channels guide LEC migration and formation of a functional lymphatic capillary network. Importantly, these processes take place only in the direction of interstitial flow [26].

In line with these results, reduced interstitial flow during tissue regeneration results in decreased LEC migration and lymphatic vasculature formation. VEGF-C administration fails to induce lymphangiogenesis in this setting [27]. During skin regeneration, MMPs activity and VEGF-C expression are more pronounced at the upstream than the downstream of interstitial flow [26]. These data suggest that MMPs and VEGF-C transport are likely directed by interstitial fluid flow [26]. Consistent with this hypothesis, reduced interstitial flow results in significantly increased sub-dermal MMPs and VEGF-C accumulation [27]. Together, these data suggest that growth factors and proteases transported by interstitial flow may be important for lymphatic vasculature formation [27].

Interestingly, in the tail skin regeneration model, BEC migration and vascular network organization in CDE are not directional [26] indicating that LECs and BECs have different genetic programs in response to interstitial fluid flow.

Interstitial fluid also generates pressure, which has recently been shown to be involved in lymphangiogenesis in mice. In developing mouse embryos, the volume of fluid in the interstitium is correlated with LEC morphologic changes, proliferation and lymphatic vessel expansion [28]. In response to increased interstitial fluid, LECs become elongated, show increased proliferation and enhanced VEGFR3 tyrosine phosphorylation. In contrast, a reduction in the amount of interstitial fluid causes the opposite effect – reduced LEC proliferation and decreased VEGFR3 phosphorylation [28]. Although LECs become elongated in response to changes in the volume of interstitial fluid, this elongation requires a molecular mediator that converts the fluid-induced mechanical forces to the observed cellular responses. It appears that β1 integrins play the role of “mediator” in this process [28]. When the amount of interstitial fluid is increased, β1 integrins are activated, which subsequently activates Src Family Kinases (SFKs) and the activation of SFKs results in tyrosine phosphorylation of VEGFR3 [28].

Flow in lymphatic valve development

A recent study has identified lymph flow as a factor that regulates lymphatic valve development during lymphatic remodeling [29]. Lymphatic valves form in collecting lymphatic vessels, thereby preventing back flow of lymph. This is a complex process that involves a large number of genes and a variety of intracellular signaling pathways (reviewed by [30] which include ephrin-B2, Foxc2, Prox1, connexins, Ang2, and integrin-α9/FN-EIIIA, Sema3A/NRP1 and calcineurin/NFATc1 signaling [29, 3139].

In mice, lymph flow in mesenteric lymphatic vessels commences on embryonic day (E) 15.5 and at this time lymphatic valves have not yet formed [29]. As a result, reverse lymph flow does occur in many places, especially at vessel bifurcations. This flow dynamics induce lymphatic valve development at ~ E16.0. At that time, lymphatic-valve-forming cells (LVCs) begin to express high levels of Prox1 and Foxc2, followed by the induction of Cx37 and activation of calcineurin/NFATc1 signaling [29] (Figure 1A). In cultured LECs, oscillatory fluid shear stress (OSS) that mimics lymph flow reversal occurring prior to lymphatic valve development, is able to trigger Cx37 expression and activate calcineurin/NFATc1 signaling as indicated by the nuclear accumulation of the transcription factor NFATc1 [29]. This process is also dependent upon the expression levels of PROX1 and FOXC2.
Figure 1

Fluid flow in lymphatic vasculature development in mice. (A) Flow triggers lymphatic valve development. At approximately embryonic day (E)16.0, lymph flow induces Cx37 expression and activates calcineurin/NFATc1 signaling in lymphatic-valve-forming cells initiating luminal valve development. (B) Fluid flow plays a role in lymphatic fate maintenance. In mice, loss of Slp-76 results in shunt formation between blood and lymphatic vessels in mesentery and, therefore mixing of blood and lymphatic circulation. The presence of blood flow in lymphatic vessels in Slp-76 null mice causes the change of lymphatic fate to a venous identity.

Upon exposure to OSS, LECs with high levels of PROX1 and FOXC2 accumulate NFATc1 in the nucleus, which does not occur in LECs expressing low levels of PROX1 and FOXC2. These data suggest that flow-induced shear stress activates distinct signaling pathways in different LEC populations [29]. Together, both the in vivo and in vitro data support the notion that lymph flow is involved in triggering lymphatic valve formation.

Furthermore, it now appears that different types of flow shear stress result in distinct cell morphology and actin cytoskeleton organization changes in LECs [29]. When subjected to OSS, LECs adapt a more cuboidal shape and have increased amounts of short perinuclear F-actin stress fibers, which are hallmarks of LVCs in vivo. Upon laminar shear stress (LSS), LECs become elongated, align in the direction of flow and form stress fibers, reminiscent of LECs (lymphangion cells) that express low levels of Prox1 and Foxc2 and are located adjacent to LVCs [29].

Similar to lymphatic vessels, veins also have luminal valves. Interestingly, both venous and lymphatic valve ECs share common molecular regulators [40]. For instance, molecules such as Prox1, ephrin-B2, Vegfr3 and integrin-α9 that are important for lymphatic valve development are also expressed in venous valve ECs [40]. These data suggest common signaling pathways are involved in venous and lymphatic valve formation. Fluid flow mediates distinct shear forces in veins and in lymphatic vessels. It remains intriguing to investigate the role of flow in venous valve development and how different shear forces regulate luminal valve formation in veins and lymphatic vessels through common molecular regulators.

Fluid flow and lymphatic fate maintenance

Fluid flow is also important in the lymphatic fate maintenance. SLP-76 is a hematopoietic intracellular signaling protein, which has been shown to be required for blood and lymphatic vascular separation [4143]. In mice, loss of Slp-76 results in the formation of abnormal connections between blood and lymphatic vessels, and thus mixing of blood and lymphatic circulation [4143]. Moreover, mesenteric lymphatic vessels in Slp-76 null mice lose their lymphatic fate and adapt a venous identity [43] (Figure 1B). This phenotype has been attributed to the presence of blood flow in mesenteric lymphatic vessels in SLP-76 deficient mice and it is not due to a response to factors in the blood that are not present in the lymph [43]. These findings highlight the importance of hemodynamic forces in the maintenance of LEC identity even though the molecular mechanisms underlying this process remain unknown.

Conclusions

Recent research advances have largely improved our knowledge on gene products and signaling pathways involved in lymphatic vascular development and have expanded the list of players that contribute to this process. An increasing amount of evidence has elevated the importance of fluid flow in the formation of lymphatic vasculature. Although our understanding of the molecular mechanism(s) underlying flow-regulated lymphatic vascular development is very limited, the importance of fluid flow in this process will draw increasing research efforts and will help to gain further insight into this fascinating research area.

Declarations

Acknowledgments

We thank A. Lanahan for editing of the manuscript. This review was supported in part by NIH grant R01 HL062289 (M.S.).

Authors’ Affiliations

(1)
Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine
(2)
Department of Cell Biology, Yale University School of Medicine

References

  1. Brown JD, DiChiara MR, Anderson KR, Gimbrone MA, Topper JN: MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J Biol Chem. 1999, 274: 8797-8805.View ArticlePubMedGoogle Scholar
  2. Chien S, Li S, Shyy JY: Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension. 1998, 31: 162-169.View ArticlePubMedGoogle Scholar
  3. Topper JN, Gimbrone MA: Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol Med Today. 1999, 5: 40-46.View ArticlePubMedGoogle Scholar
  4. Wasserman SM, Topper JN: Adaptation of the endothelium to fluid flow: in vitro analyses of gene expression and in vivo implications. Vasc Med. 2004, 9: 35-45.View ArticlePubMedGoogle Scholar
  5. Chiu J-J, Usami S, Chien S: Vascular endothelial responses to altered shear stress: pathologic implications for atherosclerosis. Ann Med. 2009, 41: 19-28.View ArticlePubMedGoogle Scholar
  6. Gimbrone MA, Topper JN, Nagel T, Anderson KR, Garcia-Cardeña G: Endothelial dysfunction, hemodynamic forces, and atherogenesisa. Ann N Y Acad Sci. 2000, 902: 230-240.View ArticlePubMedGoogle Scholar
  7. Malek AM, Alper SL, Izumo S: Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999, 282: 2035-2042.View ArticlePubMedGoogle Scholar
  8. Zhou J, Li Y-S, Nguyen P, Wang K-C, Weiss A, Kuo Y-C, Chiu J-J, Shyy JY, Chien S: Regulation of vascular smooth muscle cell turnover by endothelial cell–secreted microRNA-126 role of shear stress. Circ Res. 2013, 113: 40-51.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Wang Y, Oliver G: Current views on the function of the lymphatic vasculature in health and disease. Genes Dev. 2010, 24: 2115-2126.PubMed CentralView ArticlePubMedGoogle Scholar
  10. Harvey NL, Srinivasan RS, Dillard ME, Johnson NC, Witte MH, Boyd K, Sleeman MW, Oliver G: Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet. 2005, 37: 1072-1081.View ArticlePubMedGoogle Scholar
  11. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN: Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000, 25: 153-159.View ArticlePubMedGoogle Scholar
  12. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H: Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004, 5: 74-80.View ArticlePubMedGoogle Scholar
  13. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park J-K, Beck F-X, Müller DN, Derer W: Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism. Nat Med. 2009, 15: 545-552.View ArticlePubMedGoogle Scholar
  14. Martel C, Li W, Fulp B, Platt AM, Gautier EL, Westerterp M, Bittman R, Tall AR, Chen S-H, Thomas MJ: Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest. 2013, 123: 1571-PubMed CentralView ArticlePubMedGoogle Scholar
  15. Wigle JT, Oliver G: Prox1 function is required for the development of the murine lymphatic system. Cell. 1999, 98: 769-778.View ArticlePubMedGoogle Scholar
  16. Ng CP, Helm C-LE, Swartz MA: Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc Res. 2004, 68: 258-264.View ArticlePubMedGoogle Scholar
  17. Breslin JW, Kurtz KM: Lymphatic endothelial cells adapt their barrier function in response to changes in shear stress. Lymphat Res Biol. 2009, 7: 229-237.PubMed CentralView ArticlePubMedGoogle Scholar
  18. Baumer Y, Spindler V, Werthmann R, Bünemann M, Waschke J: Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin‒induced barrier breakdown. J Cell Physiol. 2009, 220: 716-726.View ArticlePubMedGoogle Scholar
  19. Birukova AA, Liu F, Garcia JG, Verin AD: Protein kinase A attenuates endothelial cell barrier dysfunction induced by microtubule disassembly. Am J Physiol Lung Cell Mol Physiol. 2004, 287: L86-L93.View ArticlePubMedGoogle Scholar
  20. Durán WN, Sánchez FA, Breslin JW: Microcirculatory exchange function. Handbook of Physiology: Microcirculation. Edited by: Tuma RF, Dura’n WN, Ley K. 2008, San Diego, CA: Academic Press–Elsevier, 81-124. 2View ArticleGoogle Scholar
  21. He P, Zeng M, Curry F: Dominant role of cAMP in regulation of microvessel permeability. Am J Physiol Heart Circ Physiol. 2000, 278: H1124-H1133.PubMedGoogle Scholar
  22. Qiao J, Huang F, Lum H: PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2003, 284: L972-L980.View ArticlePubMedGoogle Scholar
  23. Shikata Y, Rios A, Kawkitinarong K, DePaola N, Garcia JG, Birukov KG: Differential effects of shear stress and cyclic stretch on focal adhesion remodeling, site-specific FAK phosphorylation, and small GTPases in human lung endothelial cells. Exp Cell Res. 2005, 304: 40-49.View ArticlePubMedGoogle Scholar
  24. Waschke J, Drenckhahn D, Adamson R, Barth H, Curry F: cAMP protects endothelial barrier functions by preventing Rac-1 inhibition. Am J Physiol Heart Circ Physiol. 2004, 287: H2427-H2433.View ArticlePubMedGoogle Scholar
  25. Helm C-LE, Fleury ME, Zisch AH, Boschetti F, Swartz MA: Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc Natl Acad Sci U S A. 2005, 102: 15779-15784.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Boardman KC, Swartz MA: Interstitial flow as a guide for lymphangiogenesis. Circ Res. 2003, 92: 801-808.View ArticlePubMedGoogle Scholar
  27. Goldman J, Conley KA, Raehl A, Bondy DM, Pytowski B, Swartz MA, Rutkowski JM, Jaroch DB, Ongstad EL: Regulation of lymphatic capillary regeneration by interstitial flow in skin. Am J Physiol Cell Physiol. 2007, 61: H2176-View ArticleGoogle Scholar
  28. Planas-Paz L, Strilić B, Goedecke A, Breier G, Fässler R, Lammert E: Mechanoinduction of lymph vessel expansion. EMBO J. 2012, 31: 788-804.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Sabine A, Agalarov Y, Maby-El Hajjami H, Jaquet M, Hägerling R, Pollmann C, Bebber D, Pfenniger A, Miura N, Dormond O: Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell. 2012, 22: 430-445.View ArticlePubMedGoogle Scholar
  30. Bazigou E, Makinen T: Flow control in our vessels: vascular valves make sure there is no way back. Cell Mol Life Sci. 2013, 70: 1055-1066.PubMed CentralView ArticlePubMedGoogle Scholar
  31. Bazigou E, Xie S, Chen C, Weston A, Miura N, Sorokin L, Adams R, Muro AF, Sheppard D, Makinen T: Integrin-α9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell. 2009, 17: 175-186.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Bouvrée K, Brunet I, del Toro R, Gordon E, Prahst C, Cristofaro B, Mathivet T, Xu Y, Soueid J, Fortuna V: Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. Circ Res. 2012, 111: 437-445.View ArticlePubMedGoogle Scholar
  33. Dellinger M, Hunter R, Bernas M, Gale N, Yancopoulos G, Erickson R, Witte M: Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev Biol. 2008, 319: 309-320.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Jurisic G, Maby-El Hajjami H, Karaman S, Ochsenbein AM, Alitalo A, Siddiqui SS, Pereira CO, Petrova TV, Detmar M: An Unexpected Role of Semaphorin3A–Neuropilin-1 Signaling in Lymphatic Vessel Maturation and Valve Formation. Circ Res. 2012, 111: 426-436.PubMed CentralView ArticlePubMedGoogle Scholar
  35. Kanady JD, Dellinger MT, Munger SJ, Witte MH, Simon AM: Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol. 2011, 354: 253-266.PubMed CentralView ArticlePubMedGoogle Scholar
  36. Kulkarni RM, Greenberg JM, Akeson AL: NFATc1 regulates lymphatic endothelial development. Mech Dev. 2009, 126: 350-365.PubMed CentralView ArticlePubMedGoogle Scholar
  37. Mäkinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, Wilkinson GA: PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 2005, 19: 397-410.PubMed CentralView ArticlePubMedGoogle Scholar
  38. Norrmén C, Ivanov KI, Cheng J, Zangger N, Delorenzi M, Jaquet M, Miura N, Puolakkainen P, Horsley V, Hu J: FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol. 2009, 185: 439-457.PubMed CentralView ArticlePubMedGoogle Scholar
  39. Petrova TV, Karpanen T, Norrmén C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Ylä-Herttuala S: Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med. 2004, 10: 974-981.View ArticlePubMedGoogle Scholar
  40. Bazigou E, Lyons OT, Smith A, Venn GE, Cope C, Brown NA, Makinen T: Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest. 2011, 121: 2984-PubMed CentralView ArticlePubMedGoogle Scholar
  41. Abtahian F, Guerriero A, Sebzda E, Lu M-M, Zhou R, Mocsai A, Myers EE, Huang B, Jackson DG, Ferrari VA: Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science. 2003, 299: 247-251.PubMed CentralView ArticlePubMedGoogle Scholar
  42. Bertozzi CC, Schmaier AA, Mericko P, Hess PR, Zou Z, Chen M, Chen C-Y, Xu B, M-m L, Zhou D: Platelets regulate lymphatic vascular development through CLEC-2–SLP-76 signaling. Blood. 2010, 116: 661-670.PubMed CentralView ArticlePubMedGoogle Scholar
  43. Chen C-Y, Bertozzi C, Zou Z, Yuan L, Lee JS, Lu M, Stachelek SJ, Srinivasan S, Guo L, Vincente A: Blood flow reprograms lymphatic vessels to blood vessels. J Clin Invest. 2012, 122: 2006-PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Wang and Simons; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement